Mitsubishi Electric, ME Innovation Fund Invests in SCADAfence Ltd.
Strengthening of the OT security platform for the manufacturing industry which enables user to reveal…
3 years ago
Wire Stories
Toshiba Releases 150V N-channel Power MOSFET with Industry-leading[1] Low On-resistance and Improved Reverse Recovery Characteristics that Help Increase the Efficiency of Power Supplies
KAWASAKI, Japan--(BUSINESS WIRE)--Toshiba Electronic Devices & Storage Corporation ("Toshiba") has launched a 150V N-channel power…
3 years ago
TDCX levels up in Vietnam to help its gaming clients deliver a good game
NYSE-listed digital customer experience solutions provider expands its Southeast Asian footprint with the opening of…
3 years ago
Unleash the nightmare: “Tokyo Dark -Remembrance-” Horror Adventure Arrives to iOS!
TOKYO--(BUSINESS WIRE)--mebius. (Location: Mitaka City, Tokyo, CEO: Asako Mori), creator, developer, and distributor of computer…
3 years ago
Boomi Partners with Leading Japanese ERP Provider To Accelerate Digital Transformation in Japan
New channel partnership builds upon Boomi’s increased investment in Japan to meet growing global demand…
3 years ago
Booktopia and VitalSource Launch Digital Textbook Partnership
Booktopia customers have access to digital textbooks for the first time through VitalSource’s best-in-class technology…
3 years ago
Blue Ocean Smart System Unveils Chiplet-Based Products Powered by VeriSilicon’s High-Performance Processors
Deliver 8 TFLOPS in a GPGPU chiplet package, 240 TOPS in a NPU chiplet package…
3 years ago
Medical Properties Trust Announces Agreement to Sell Healthscope Portfolio
Cash Proceeds of Approximately AUD$1.2 Billion to Fully Prepay Term Loan Maturing in 2024 Investor…
3 years ago
Medical Properties Trust Announces Agreement to Sell Healthscope Portfolio
Cash Proceeds of Approximately AUD$1.2 Billion to Fully Prepay Term Loan Maturing in 2024 Investor…
3 years ago
AN2 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights
Approaching 60 clinical sites participating in pivotal Phase 2/3 trial of epetraborole in treatment-refractory Mycobacterium…
3 years ago